Mealey's (June 6, 2019, 11:45 AM EDT) -- BOSTON — A subsidiary of opioid manufacturer Insys Therapeutics Inc. on June 5 pleaded guilty to mail fraud and the parent company agreed to pay $225 million in fines, forfeiture and civil settlement of five whistleblower lawsuits alleging that the company paid kickbacks to doctors to prescribe the fentanyl-based pain drug Subsys (United States of America v. Insys Therapeutics, Inc., et al., No. 19-cr-10191, D. Mass.)....